Aspira Women's Health President resigns; appoints new director Ellen Beausang

Aspira Women's Health Inc.

Dr. Sandra Milligan resigns as President effective Feb 21, 2025, for personal reasons.
Duties assumed by Jamie Sullivan (Chief of Staff) and Todd Pappas (VP R&D and Lab Ops).
Ellen Beausang appointed to board; she is President/Chief Commercial Officer of BioReference Health (since June 2022).
Beausang brings 25+ years experience from Pfizer, Thermo Fisher, Quest Diagnostics; no arrangement or related-party transactions.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Sandra Milligan

President

AWHL · Aspira Women's Health Inc.

Effective: 2025-02-21
Filed: February 10, 2025, 6:59 PM ET

Dr. Sandra Milligan, the President of Aspira Women’s Health Inc. (the “Company”) informed the Board of Directors of the Company that she was resigning as President of the Company for personal reasons, effective February 21, 2025.

Appointed

Ellen Beausang

Director

AWHL · Aspira Women's Health Inc.

Effective: 2025-02-06
Filed: February 10, 2025, 6:59 PM ET

the Board of Directors of the Company appointed Ellen Beausang as a director of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Sandra Milligan resigned as President at Aspira Women's Health Inc..

Action: resigned
Role: President

Exact text from the filing

Dr. Sandra Milligan, the President of Aspira Women’s Health Inc. (the “Company”) informed the Board of Directors of the Company that she was resigning as President of the Company for personal reasons, effective February 21, 2025.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Ellen Beausang was appointed as Director at Aspira Women's Health Inc..

Action: appointed
Role: Director

Exact text from the filing

the Board of Directors of the Company appointed Ellen Beausang as a director of the Company.

View on SEC.gov

Aspira Women's Health Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-005666

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.